Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations

Zhuoer Xie, Jenna Fernandez, Terra Lasho, Christy Finke, Michelle Amundson, Kristen B. McCullough, Betsy R. LaPlant, Abhishek A. Mangaonkar, Naseema Gangat, Kaaren K. Reichard, Michelle Elliott, Thomas E. Witzig, Mrinal M. Patnaik

Blood (2024) 144 (23): 2456–2461.

https://doi.org/10.1182/blood.2024024962

Published: 2024

Includes: Supplemental data

Journal Articles

Outcome of Myelodysplastic Syndromes over Time in the US: A National Cancer Data Base Study from 2004-2013

Aref Al-Kali, MD, Darci Zblewski, CNP, Adam C Bartley, MS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Ayalew Tefferi, MD, Michelle Elliott, MD, William J Hogan, MBChB, Mark R. Litzow, MD, Ronald S. Go, MD

Blood (2016) 128 (22): 3604.

https://doi.org/10.1182/blood.V128.22.3604.3604

Published: 2016

Journal Articles

Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience

Aref Al-Kali, MD, Rong He, MD, Mrinal M Patnaik, MBBS, David S Viswanatha, MD, Patricia T. Greipp, DO, Darci Zblewski, CNP, Michelle Elliott, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Mark R. Litzow, MD, Phuong L. Nguyen, MD

Blood (2016) 128 (22): 5541.

https://doi.org/10.1182/blood.V128.22.5541.5541

Published: 2016

Journal Articles

Spectrum of Concomitant and Subsequently Diagnosed Second Malignancies in Patients with Chronic Myelomonocytic Leukemia

Daniela Barraco, MD, Terra L. Lasho, PhD, Christy Finke, BS, Aref Al-Kali, MD, Michelle Elliott, MD, Mark R. Litzow, MD, Naseema Gangat, MBBS, Curtis A. Hanson, MD, Ayalew Tefferi, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 1989.

https://doi.org/10.1182/blood.V128.22.1989.1989

Published: 2016

Journal Articles

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Jennifer Yui, MD, Mythri Mudireddy, MBBS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Aref Al-Kali, MD, Michelle Elliott, MD, William J. Hogan, MBChB, C. Christopher Hook, MD, Alexandra P Wolanskyj, MD, Mark R. Litzow, MD, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Kebede H. Begna, MD

Blood (2016) 128 (22): 2798.

https://doi.org/10.1182/blood.V128.22.2798.2798

Published: 2016

Journal Articles

Deficiency of Current Acute Myeloid Leukemia (AML) Response Criteria to Predict Response to Hypomethylating Agent Therapy: The Value of Long-Lasting Stable Disease

Stephanie Williams, MD, Rama Nanah, MD, Darci Zblewski, CNP, Michelle Elliott, MD, William J. Hogan, MBChB, Raoul Tibes, MD PhD, James M. Foran, MD, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2016) 128 (22): 2799.

https://doi.org/10.1182/blood.V128.22.2799.2799

Published: 2016

Journal Articles

Monocytosis Is a Powerful and Independent Predictor of Shortened Overall and Leukemia-Free Survival in Primary Myelofibrosis

Sahrish Shah, MBBS, Mythri Mudireddy, MBBS, Terra L. Lasho, PhD, Daniela Barraco, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Michelle Elliott, MD, Animesh Pardanani, Ayalew Tefferi, MD

Blood (2016) 128 (22): 4249.

https://doi.org/10.1182/blood.V128.22.4249.4249

Published: 2016

Journal Articles

Clinical Outcome of Therapy-Related Acute Myeloid Leukemia Is Strongly Related to Cytogenetic Analysis

Croix Fossum, BS, Rhett P. Ketterling, MD, Lindsey E. Roeker, Ajoy L. Dias, MD, Michelle Elliott, MD, William J. Hogan, MBChB, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2015) 126 (23): 1401.

https://doi.org/10.1182/blood.V126.23.1401.1401

Published: 2015

Journal Articles

The Adverse Impact of Age and Central Nervous System Involvement on Survival in Adult T-ALL, an Analysis of 92 Consecutive Patients

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Tasha Lin, MD, Mehrdad Hefazi, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, William J. Hogan, MBChB, Michelle Elliott, MD, Grzegorz S. Nowakowski, MD, Carrie Thompson, MD, Thomas E. Witzig, MD, Stephen M Ansell, MD, PhD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4993.

https://doi.org/10.1182/blood.V126.23.4993.4993

Published: 2015

Journal Articles

Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Tasha Lin, MD, Aref Al-Kali, MD, Lisa Sproat, MD MSW, Jeffrey Alan Betcher, BSPharm, RPh, Jason N. Barreto, PharmD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Michelle Elliott, MD, Mark R Litzow, MD, William J Hogan, MBChB

Blood (2015) 126 (23): 4910.

https://doi.org/10.1182/blood.V126.23.4910.4910

Published: 2015

Journal Articles

Response to Hypomethylating Agents in Myelodysplastic Syndromes Based on WHO 2008 Subtypes and IPSS-R Stratification and Impact on Survival

Hassan B Alkhateeb, MD, Muhanad Hreh, Moussab Damlaj, MD, Michelle Elliott, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS, Mark R Litzow, MD, Aref Al-Kali, MD

Blood (2015) 126 (23): 5260.

https://doi.org/10.1182/blood.V126.23.5260.5260

Published: 2015

Journal Articles

Clinical Characteristics and Outcome of Adult Acute Erythroleukemia; Mayo Clinic Experience

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, William J Hogan, MBChB, Michelle Elliott, MD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4980.

https://doi.org/10.1182/blood.V126.23.4980.4980

Published: 2015

Journal Articles

Survival Trends in Adult T-Acute Lymphoblastic Leukemia / Lymphoma (ALL), a Comparative Analysis of 92 Patients By Year of Diagnosis

Hassan B Alkhateeb, MD, Tasha Lin, MD, Moussab Damlaj, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, William J Hogan, MBChB, Michelle Elliott, MD, Grzegorz S. Nowakowski, MD, Carrie Thompson, MD, Thomas E. Witzig, MD, Stephen M Ansell, MD, PhD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 2490.

https://doi.org/10.1182/blood.V126.23.2490.2490

Published: 2015

Journal Articles

Disparity in the Overall Survival Improvement over Time and the Effect Time-to-Treatment on the Outcome of Acute Promyelocytic Leukemia: A US National Cancer Data Base Study from 1998-2011

Aref Al-Kali, MD, Raoul Tibes, MD PhD, James M. Foran, MD, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Adam C Bartley, MS, Michelle Elliott, MD, Mark R Litzow, MD, Ronald S. Go, MD

Blood (2015) 126 (23): 3747.

https://doi.org/10.1182/blood.V126.23.3747.3747

Published: 2015

Journal Articles

Clinical Outcome of Patients Diagnosed with Myelodysplastic Syndrome-Unclassifiable (MDS-U): Single Center Experience

Firas Baidoun, MD, Dong Chen, MD PhD, Hassan Alkhateeb, MD, Darci Zblewski, CNP, Michelle Elliott, MD, William J. Hogan, MBChB, Mark Litzow, Aref Al-Kali, MD

Blood (2014) 124 (21): 3264.

https://doi.org/10.1182/blood.V124.21.3264.3264

Published: 2014

Journal Articles

NPM1 +/ FLT3 - Patients with Acute Myeloid Leukemia (AML) Have Excellent Clinical Outcome Independent of Age When Treated with Cytotoxic Chemotherapy: Mayo Clinic Experience

Mehrdad Hefazi Torghabeh, MD, Mustaqeem A Siddiqui, MD, Mrinal M. Patnaik, MBBS, Alexandra Wolanskyj, MD, Darci Zblewski, CNP, Michelle Elliott, MD, William J Hogan, MD, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2014) 124 (21): 5331.

https://doi.org/10.1182/blood.V124.21.5331.5331

Published: 2014

Journal Articles

Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies

Meera Sridharan, MD, PhD, Aref Al-Kali, MD, Aneel A. Ashrani, MBBS, MSc, Kebede Begna, MD, Michelle Elliott, William J. Hogan, MBChB, Carl C. Hook, MD, Scott H. Kaufmann, MD, PhD, Louis Letendre, MD, Mark R. Litzow, MD, Mrinal M. Patnaik, MBBS, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Alexandra Wolanskyj, MD, Rajiv K. Pruthi, MBBS

Blood (2013) 122 (21): 5000.

https://doi.org/10.1182/blood.V122.21.5000.5000

Published: 2013

Journal Articles

Correlation Of Outcomes Of Allogeneic Stem Cell Transplants For Chronic Myelomonocytic Leukemia With The Mayo Prognostic Model

Michelle T Patzelt, BS, Mark R. Litzow, MD, William Hogan, MD, Shahrukh K Hashmi, MD, Michelle Elliott, MD, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS

Blood (2013) 122 (21): 5226.

https://doi.org/10.1182/blood.V122.21.5226.5226

Published: 2013

Journal Articles

Monosomal Karyotype Predicts Adverse Prognosis In Patients With Chronic Myelomonocytic Leukemia

Aysha K Alsahlawi, Hassan Alkhateeb, MD, Mrinal M. Patnaik, MBBS, Kebede Begna, MD, Michelle Elliott, MD, William Hogan, MD, Rhett P Ketterling, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2013) 122 (21): 1334.

https://doi.org/10.1182/blood.V122.21.1334.1334

Published: 2013

Journal Articles

Cytogenetic Abnormalities Predict Clinical Outcome In Patients Diagnosed With Relapsed Acute Myeloid Leukemia (rAML): Single Center Experience

Hassan Alkhateeb, MD, Rhett P Ketterling, Niamh Keane, Mrinal M Patnaik, MBBS, Animesh Pardanani, MBBS, PhD, Michelle Elliott, MD, William J Hogan, MD, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2013) 122 (21): 4955.

https://doi.org/10.1182/blood.V122.21.4955.4955

Published: 2013

NARROW

High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations

Outcome of Myelodysplastic Syndromes over Time in the US: A National Cancer Data Base Study from 2004-2013

Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience

Spectrum of Concomitant and Subsequently Diagnosed Second Malignancies in Patients with Chronic Myelomonocytic Leukemia

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Deficiency of Current Acute Myeloid Leukemia (AML) Response Criteria to Predict Response to Hypomethylating Agent Therapy: The Value of Long-Lasting Stable Disease

Monocytosis Is a Powerful and Independent Predictor of Shortened Overall and Leukemia-Free Survival in Primary Myelofibrosis

Clinical Outcome of Therapy-Related Acute Myeloid Leukemia Is Strongly Related to Cytogenetic Analysis

The Adverse Impact of Age and Central Nervous System Involvement on Survival in Adult T-ALL, an Analysis of 92 Consecutive Patients

Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

Response to Hypomethylating Agents in Myelodysplastic Syndromes Based on WHO 2008 Subtypes and IPSS-R Stratification and Impact on Survival

Clinical Characteristics and Outcome of Adult Acute Erythroleukemia; Mayo Clinic Experience

Survival Trends in Adult T-Acute Lymphoblastic Leukemia / Lymphoma (ALL), a Comparative Analysis of 92 Patients By Year of Diagnosis

Disparity in the Overall Survival Improvement over Time and the Effect Time-to-Treatment on the Outcome of Acute Promyelocytic Leukemia: A US National Cancer Data Base Study from 1998-2011

Clinical Outcome of Patients Diagnosed with Myelodysplastic Syndrome-Unclassifiable (MDS-U): Single Center Experience

NPM1 +/ FLT3 - Patients with Acute Myeloid Leukemia (AML) Have Excellent Clinical Outcome Independent of Age When Treated with Cytotoxic Chemotherapy: Mayo Clinic Experience

Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies

Correlation Of Outcomes Of Allogeneic Stem Cell Transplants For Chronic Myelomonocytic Leukemia With The Mayo Prognostic Model

Monosomal Karyotype Predicts Adverse Prognosis In Patients With Chronic Myelomonocytic Leukemia

Cytogenetic Abnormalities Predict Clinical Outcome In Patients Diagnosed With Relapsed Acute Myeloid Leukemia (rAML): Single Center Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only